The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Abstract
Daptomycin is a lipopeptide antibiotic with potent activity against gram-positive bacteria. Complete-genome comparisons of laboratory-derived Staphylococcus aureus with decreased susceptibility to daptomycin and their susceptible parent were used to identify genes that contribute to reduced susceptibility to daptomycin. Selective pressure of growth in sublethal concentrations of daptomycin resulted in the accumulation of mutations over time correlating with incremental decreases in susceptibility. Single point mutations resulting in amino acid substitutions occurred in three distinct proteins: MprF, a lysylphosphatidylglycerol synthetase; YycG, a histidine kinase; and RpoB and RpoC, the β and β′ subunits of RNA polymerase. Sequence analysis of mprF , yycF , yycG , rpoB , and rpoC in clinical isolates that showed treatment-emergent increases in daptomycin MICs revealed point mutations in mprF and a nucleotide insertion in yycG , suggesting a role for these genes in decreased susceptibility to daptomycin in the hospital setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Whole genome sequencing of meticillin-resistant Staphylococcus aureus
Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, I., Cui, L., Oguchi, A., Aoki, K.-I., Nagai, Y., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04403-2 · Cited by 1,961
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Gill, S. R., Fouts, D. E., Archer, G. L., Mongodin, E. F., DeBoy, R. T., Ravel, J., Paulsen, I. T., Kolonay, J. F., Brinkac, L., Beanan, M., et al. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2426-2438.2005 · Cited by 1,026
Holden, M. T. G., Feil, E. J., Lindsay, J. A., Peacock, S. J., Day, N. P. J., Enright, M. C., Foster, T. J., Moore, C. E., Hurst, L., Atkin, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402521101 · Cited by 892
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Self-citationFitzgerald, J. R., Sturdevant, D. E., Mackie, S. M., Gill, S. R., & Musser, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161098098 · Cited by 434
Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC
Ito, T., Okuma, K., Ma, X. X., Yuzawa, H., & Hiramatsu, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00003-7 · Cited by 424
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320 · cited 1×
“Single nucleotide changes confer resistance to a wide range of antimicrobials, including rifampin, fluoroquinolones, and quinupristin-dalfopristin (8, 9, 15, 24, 42).”
BackgroundStructural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Role in Cell Permeability of an Essential Two-Component System in Staphylococcus aureus
Martin, P. K., Li, T., Sun, D., Biek, D. P., & Schmid, M. B. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.12.3666-3673.1999 · Cited by 242
Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Resistance Studies with Daptomycin
Silverman, J. A., Oliver, N., Andrew, T., & Li, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1799-1802.2001 · Cited by 234
Self-citationMidorikawa, K., Ouhara, K., Komatsuzawa, H., Kawai, T., Yamada, S., Fujiwara, T., Yamazaki, K., Sayama, K., Taubman, M. A., Kurihara, H., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.7.3730-3739.2003 · Cited by 234
Dubrac, S., & Msadek, T. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.1175-1181.2004 · Cited by 228
Mechanism of action of the oxazolidinone antibacterial agents
Shinabarger, D. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.8.1195 · Cited by 211
Mutation discovery in bacterial genomes: metronidazole resistance in Helicobacter pylori
Albert, T. J., Dailidiene, D., Dailide, G., Norton, J. E., Kalia, A., Richmond, T. A., Molla, M., Singh, J., Green, R. D., & Berg, D. E. (2005) · Nature Methods · doi:10.1038/nmeth805 · Cited by 204
Linezolid Resistance inStaphylococcus aureus:Characterization and Stability of Resistant Phenotype
Pillai, S. K., Sakoulas, G., Wennersten, C. B., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/345368 · Cited by 193
Staubitz, P., Neumann, H., Schneider, T., Wiedemann, I., & Peschel, A. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00921-2 · Cited by 171
Howell, A., Dubrac, S., Andersen, K. K., Noone, D., Fert, J., Msadek, T., & Devine, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03661.x · Cited by 165
Fukuchi, K., Kasahara, Y., Asai, K., Kobayashi, K., Moriya, S., & Ogasawara, N. (2000) · Microbiology · doi:10.1099/00221287-146-7-1573 · Cited by 161
Escherichia coli RNA Polymerase Is the Target of the Cyclopeptide Antibiotic Microcin J25
Delgado, M. A., Rintoul, M. R., Farı́as, R. N., & Salomón, R. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.15.4543-4550.2001 · Cited by 158
Nishi, H., Komatsuzawa, H., Fujiwara, T., Holmes, N., & Sugai, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4800-4807.2004 · Cited by 151
Mutations of Bacterial RNA Polymerase Leading to Resistance to Microcin J25
Yuzenkova, J., Delgado, M. A., Nechaev, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209425200 · Cited by 147
Oku, Y., Kurokawa, K., Ichihashi, N., & Sekimizu, K. (2003) · Microbiology · doi:10.1099/mic.0.26706-0 · Cited by 130
Wong, C. W., Albert, T. J., Vega, V. B., Norton, J. E., Cutler, D. J., Richmond, T., Stanton, L. W., Liu, E. T., & Miller, L. D. (2004) · Genome Research · doi:10.1101/gr.2141004 · Cited by 127
Kristian, S. A., Dürr, M. C., van Strijp, J. A. G., Neumeister, B., & Peschel, A. (2002) · Infection and Immunity · doi:10.1128/iai.71.1.546-549.2003 · Cited by 122
Critchley, I. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg130 · Cited by 113
Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureus
Wichelhaus, T. A., Böddinghaus, B., Besier, S. M., Schäfer, V., Brade, V., & Ludwig, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3381-3385.2002 · Cited by 111
Vikram, H. R., Havill, N. L., Koeth, L. M., & Boyce, J. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5384-5387.2005 · Cited by 71
Malbruny, B., Canu, A., Bozdogan, B., Fantin, B., Zarrouk, V., Dutka-Malen, S., Feger, C., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2200-2207.2002 · Cited by 70
Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus
Ruzin, A. V., Severin, A. I., Moghazeh, S. L., Étienne, J., Bradford, P. A., Projan, S. J., & Shlaes, D. M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00028-x · Cited by 69
Clausen, V. A., Bae, W., Throup, J. P., Burnham, M. K. R., Rosenberg, M. J., & Wallis, N. G. (2003) · Microbial Physiology · doi:10.1159/000071077 · Cited by 36
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
Intrinsic and acquired resistance mechanisms in enterococcus
Hollenbeck, B. L., & Rice, L. B. (2012) · Virulence · doi:10.4161/viru.21282 · Cited by 795
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
Metadata
- Authors
- Friedman, L., Alder, J. D., & Silverman, J. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-06
- Volume
- 50
- Issue
- 6
- Pages
- 2137-2145
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2146894318
- Cited by
- 454
- References
- 36
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.